INSTITUTE OF LIVER AND BILIARY SCIENCES

🇮🇳India

Country: 🇮🇳India

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and Ascites

Not Applicable

Not yet recruiting

Conditions: Liver Cirrhosis

Interventions: Drug: Midodrine
Biological: albumin
Other: Standard Medical Treatment

First Posted Date: 2023-10-19

Last Posted Date: 2023-10-19

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT06091345

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy

Not Applicable

Not yet recruiting

Conditions: Partial Liver Resection
Liver Regeneration
Ursodeoxycholic Acid

Interventions: Other: Standard Medical Treatment
Drug: Ursodeoxycholic acid

First Posted Date: 2023-10-19

Last Posted Date: 2023-10-19

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 80

Registration Number: NCT06091787

Locations: 🇮🇳
Institute of Liver and Biliary Sciences, New Delhi, India

Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Not Applicable

Not yet recruiting

Conditions: Liver Cirrhosis

Interventions: Biological: 20% Albumin
Biological: 5% Albumin
Drug: Plasmalyte

First Posted Date: 2023-10-10

Last Posted Date: 2023-10-10

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 120

Registration Number: NCT06076330

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure

Not yet recruiting

Conditions: Acute on Chronic Liver Failure

First Posted Date: 2023-10-05

Last Posted Date: 2023-10-05

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 200

Registration Number: NCT06069284

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, India

To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.

Not yet recruiting

Conditions: Acute on Chronic Liver Failure

First Posted Date: 2023-10-04

Last Posted Date: 2023-10-04

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 50

Registration Number: NCT06066814

Locations: 🇮🇳
Institute of Liver & Biliary Sciences., New Delhi, Delhi, India

Spleen Stiffness as a Measure to Assess the REsponse to β Blocker Therapy (SPARE-B)

Not yet recruiting

Conditions: High Risk Esophageal Varices

First Posted Date: 2023-09-22

Last Posted Date: 2023-09-22

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 130

Registration Number: NCT06050837

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

EUS-guided Versus Percutaneous Ultrasound-guided Biopsy for Parenchymal Liver Disease

Not Applicable

Not yet recruiting

Conditions: Liver Cirrhosis

Interventions: Diagnostic Test: Percutaneous Liver Biopsy
Diagnostic Test: EUS guided liver biopsy

First Posted Date: 2023-09-21

Last Posted Date: 2023-09-21

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 90

Registration Number: NCT06047327

Locations: 🇮🇳
Institiute of liver and biliary sciences, New Delhi, India

Pentoxifylline Plus Carvedilol vs Carvedilol Monotherapy in Preventing New Decompensation in Stable Cirrhotic Patients With Prior Decompensation

Not Applicable

Not yet recruiting

Conditions: Liver Cirrhosis

Interventions: Drug: Carvedilol
Drug: Pentoxifylline

First Posted Date: 2023-09-18

Last Posted Date: 2023-10-03

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 180

Registration Number: NCT06041932

Locations: 🇮🇳
Institute of Liver & Biliary Sciences., New Delhi, Delhi, India

Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization.

Not Applicable

Not yet recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Drug: N Acetylcysteine
Other: Placebo
Drug: Dexamethasone

First Posted Date: 2023-09-15

Last Posted Date: 2023-09-15

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 150

Registration Number: NCT06039280

Locations: 🇮🇳
Institute of Liver & Biliary Sciences, New Delhi, Delhi, India

A Comparison of Flexible Endoscopic Polidocanol Liquid and Foam Sclerotherapy in Cirrhotic Patients With Bleeding From Internal Hemorrhoids

Not Applicable

Not yet recruiting

Conditions: Internal Hemorrhoid
Liver Cirrhosis

Interventions: Procedure: Foam sclerotherapy.
Procedure: Sclerotherapy with 1.5% polidocanol

First Posted Date: 2023-09-11

Last Posted Date: 2023-09-15

Lead Sponsor: Institute of Liver and Biliary Sciences, India

Target Recruit Count: 60

Registration Number: NCT06031740

Locations: 🇮🇳
Institute of Liver & Biliary Sciences (ILBS), New Delhi, Delhi, India

Home Terms & Conditions Privacy Policy